Kazu received funding from ACVO VAF for his proposal, “Evaluating a novel topical EP2 receptor agonist as a treatment for feline glaucoma”. Work generated by this study may lead to greater treatment options for cats with glaucoma. Kudos Kazu!
Kazu received funding from ACVO VAF for his proposal, “Evaluating a novel topical EP2 receptor agonist as a treatment for feline glaucoma”. Work generated by this study may lead to greater treatment options for cats with glaucoma. Kudos Kazu!